Track Bonus Biogroup's total current liabilities ($16M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Bonus Biogroup (BBIXF) currently reports a total current liabilities of $16M as of June 2026. That compares with $11M in the prior-year period — up 46.6% year over year. Use the charts on this page to explore Bonus Biogroup's total current liabilities history and peer comparisons.
Bonus Biogroup's total current liabilities increased from $11M to $16M — a 46.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Bonus Biogroup reported $16M in total current liabilities as of June 2026. That compares with $11M in the prior-year period — up 46.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bonus Biogroup, and consider following BBIXF for alerts when major investors trade the stock.
Bonus Biogroup is classified in the Healthcare sector. On total current liabilities, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BBIXF with unrelated industries.